Four stages of the same journey
The cluster is best read as a timeline. Neuralink is the earliest stage — 21 human implants, pre-revenue, a binary late-2020s regulatory path; striking demos, no business yet. Unitree is mid-commercialization — shipping legged robots at volume with revenue up 335% to ¥1.7B, but on hardware, with the software-defined business still ahead. John Deere is an incumbent retrofitting a century-old product into autonomy (See & Spray, self-driving tractors) to build a per-acre software annuity. And Intuitive Surgical is the destination — a two-decade monopoly with ~11,400 da Vinci systems installed and ~86% recurring revenue. Placed side by side, they show what each earlier stage is trying to become.
Intuitive is what 'won' looks like — and why
Intuitive Surgical is the cluster's reference point because it proves where the value actually sits. It earns ~$10B at a premium multiple not from selling robots but from the razor-and-blade model around them: every da Vinci system locks a hospital into years of high-margin instruments, service and training, so ~86% of revenue recurs. The robot is the customer-acquisition cost; the installed base is the business. That is the template every other company here is chasing — and the reason Intuitive's own risk isn't a better robot but the first credible rivals finally arriving to contest a monopoly that switching costs, not technology, protected.
The moat is the lock-in, not the hardware
Read the four together and the pattern is unmistakable: hardware leadership is necessary but never sufficient. Unitree has radical cost leadership (>90% in-house parts, ~60% gross margin) — but its own central question is whether cheap hardware becomes a durable, software-defined business, because hardware alone commoditizes. John Deere's bet is explicitly the annuity: ~500M acres and recurring revenue toward ~10% by 2030, defended by data and dealer lock-in, not by the tractor. Even Neuralink's eventual moat, if it gets one, is a vertically integrated per-procedure model. The cluster's clearest lesson: in robotics you win by owning the installed base and the switching cost, exactly as Intuitive does — the robot is just how you get there.
Capital intensity and regulation gate every one
What the four also share is that the gate is rarely the engineering — it's capital and regulation. Neuralink's entire value rests on an FDA path that is binary and years away, against less-invasive competitors. Intuitive's rivals must clear the same regulatory and clinical bar that took it two decades. John Deere rides a deep farm downturn and a right-to-repair fight. Unitree faces US security and geopolitical scrutiny on top of the software gap. Embodied AI is capital-intensive and safety-regulated by nature, which is itself a moat for whoever clears the bar first — and a multi-year wall for everyone behind them.
Where they agree — and where they split
All four agree that embodied AI is inflecting and that the durable advantage is the installed base plus switching cost, not the device. They split on stage and proof: Intuitive has the model fully built and must now defend it; John Deere is converting an incumbency into an annuity; Unitree must turn a hardware cost-lead into software economics; Neuralink must convert demos into an approved, reimbursable product at all. The demand for robots and autonomy isn't the question. Which of these reaches Intuitive's razor-and-blade endpoint — and which stalls as a hardware company or a science project — is.